CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...